Phosphocreatine

Revision as of 16:56, 20 August 2015 by WikiBot (talk | contribs) (Protected "Phosphocreatine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Template:Chembox E number
Phosphocreatine
IUPAC name 2-[Methyl-(N'-phosphonocarbamimidoyl)
amino]acetic acid
Other names Creatine phosphate
Phosphorylcreatine
Creatine-P
Identifiers
3D model (JSmol)
Abbreviations PCr
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
Properties
C4H10N3O5P
Molar mass 211.113 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

WikiDoc Resources for Phosphocreatine

Articles

Most recent articles on Phosphocreatine

Most cited articles on Phosphocreatine

Review articles on Phosphocreatine

Articles on Phosphocreatine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phosphocreatine

Images of Phosphocreatine

Photos of Phosphocreatine

Podcasts & MP3s on Phosphocreatine

Videos on Phosphocreatine

Evidence Based Medicine

Cochrane Collaboration on Phosphocreatine

Bandolier on Phosphocreatine

TRIP on Phosphocreatine

Clinical Trials

Ongoing Trials on Phosphocreatine at Clinical Trials.gov

Trial results on Phosphocreatine

Clinical Trials on Phosphocreatine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phosphocreatine

NICE Guidance on Phosphocreatine

NHS PRODIGY Guidance

FDA on Phosphocreatine

CDC on Phosphocreatine

Books

Books on Phosphocreatine

News

Phosphocreatine in the news

Be alerted to news on Phosphocreatine

News trends on Phosphocreatine

Commentary

Blogs on Phosphocreatine

Definitions

Definitions of Phosphocreatine

Patient Resources / Community

Patient resources on Phosphocreatine

Discussion groups on Phosphocreatine

Patient Handouts on Phosphocreatine

Directions to Hospitals Treating Phosphocreatine

Risk calculators and risk factors for Phosphocreatine

Healthcare Provider Resources

Symptoms of Phosphocreatine

Causes & Risk Factors for Phosphocreatine

Diagnostic studies for Phosphocreatine

Treatment of Phosphocreatine

Continuing Medical Education (CME)

CME Programs on Phosphocreatine

International

Phosphocreatine en Espanol

Phosphocreatine en Francais

Business

Phosphocreatine in the Marketplace

Patents on Phosphocreatine

Experimental / Informatics

List of terms related to Phosphocreatine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phosphocreatine, also known as creatine phosphate (CP) or PCr (Pcr), is a phosphorylated creatine molecule that serves as a rapidly mobilizable reserve of high-energy phosphates in skeletal muscle and the brain.

Chemistry

Phosphocreatine is formed from parts of three amino acids: arginine (Arg), glycine (Gly), and methionine (Met). It can be synthesized by formation of guanidinoacetate from Arg and Gly (in kidney) followed by methylation (S-adenosyl methionine is required) to creatine (in liver), and phosphorylation by creatine kinase (ATP is required) to phosphocreatine (in muscle); catabolism: dehydration to form the cyclic Schiff base creatinine. Phosphocreatine is synthesized in the liver and transported to the muscle cells, via the bloodstream, for storage.

The creatine phosphate shuttle facilitates transport of high energy phosphate from mitochondria.

Function

Phosphocreatine can anaerobically donate a phosphate group to ADP to form ATP during the first 2 to 7 seconds following an intense muscular or neuronal effort. Conversely, excess ATP can be used during a period of low effort to convert creatine to phosphocreatine. The reversible phosphorylation of creatine (i.e., both the forward and backward reaction) is catalyzed by several creatine kinases. The presence of creatine kinase (CK-MB, MB for muscle/brain) in blood plasma is indicative of tissue damage and is used in the diagnosis of myocardial infarction.[1] The cell's ability to generate phosphocreatine from excess ATP during rest, as well as its use of phosphocreatine for quick regeneration of ATP during intense activity, provides a spatial and temporal buffer of ATP concentration. In other words, phosphocreatine acts as high-energy reserve in a coupled reaction; the energy given off from donating the phosphate group is used to regenerate the other compound - in this case, ATP. Phosphocreatine plays a particularly important role in tissues that have high, fluctuating energy demands such as muscle and brain.

History

The discovery of phosphocreatine[2][3] was reported by Grace and Philip Eggleton of the University of Cambridge[4] and separately by Cyrus Fiske and Yellapragada Subbarow of the Harvard Medical School[5] in 1927. A few years later David Nachmansohn, working under Meyerhof at the Kaiser Wilhelm Institute in Dahlem, Berlin, contributed to the understanding of the phosphocreatine's role in the cell.[3]

References

  1. Schlattner, U.; Tokarska-Schlattner, M., and Wallimann, T. (2006). "Mitochondrial creatine kinase in human health and disease". Biochimica et Biophysica Acta - Molecular Basis of Disease. 1762 (2): 164–180. doi:10.1016/j.bbadis.2005.09.004. PMID 16236486.
  2. Saks, Valdur (2007). Molecular system bioenergetics: energy for life. Weinheim: Wiley-VCH. p. 2. ISBN 978-3-527-31787-5.
  3. 3.0 3.1 Ochoa, Severo (1989). Sherman, E. J.; National Academy of Sciences, eds. David Nachmansohn. Biographical Memoirs. 58. National Academies Press. pp. 357–404. ISBN 978-0-309-03938-3.
  4. Eggleton, Philip; Eggleton, Grace Palmer (1927). "The inorganic phosphate and a labile form of organic phosphate in the gastrocnemius of the frog". Biochemical Journal. 21 (1): 190–195. PMC 1251888. PMID 16743804.
  5. Fiske, Cyrus H.; Subbarao, Yellapragada (1927). "The nature of the 'inorganic phosphate' in voluntary muscle". Science. 65 (1686): 401–403. doi:10.1126/science.65.1686.401. PMID 17807679.

External links


Linked-in.jpg